Continued R & D into Alzheimer ’s disease means hope for patients, families and caregivers

More than 6 million Americans, most of them age 65 or older, live with Alzheimer ’s disease, a devastating degenerative brain disease and the most common form of dementia. After heart disease and cancer, Alzheimer’s disease is thethird leading cause of death for seniors, responsible for one out of every three deaths. Not only do patients need an effective treatment and cure, but the health care system does, too. Alzheimer ’s burden isexpected to cost the nation more than $1.1 trillion by 2050.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Alzheimer's Source Type: news